Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMNPA2C)

Drug Name

PMID24946214C3b Drug Info

Synonyms

GTPL8618; BDBM50021350

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting Proteasome beta-5 (PS beta-5)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Peptide analog 21	DMJDFS1	N. A.	N. A.	Patented	[2]
Peptide analog 23	DMDU21R	N. A.	N. A.	Patented	[2]
Peptide analog 41	DM96KXE	N. A.	N. A.	Patented	[2]
PMID29865878-Compound-53	DM6JV1W	N. A.	N. A.	Patented	[2]
PMID29865878-Compound-55	DMY52ZB	N. A.	N. A.	Patented	[2]
PMID29865878-Compound-46	DMP3MXK	N. A.	N. A.	Patented	[2]
PMID29865878-Compound-48	DMVQTR2	N. A.	N. A.	Patented	[2]
PMID29865878-Compound-51	DM0LXT2	N. A.	N. A.	Patented	[2]
PMID29865878-Compound-49	DMK0GTV	N. A.	N. A.	Patented	[2]
Peptide analog 37	DMVX71N	N. A.	N. A.	Patented	[2]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors. Eur J Med Chem. 2014 Aug 18;83:1-14.
2	A patent review of immunoproteasome inhibitors.Expert Opin Ther Pat. 2018 Jul;28(7):517-540.